Status:
COMPLETED
Salivary Markers in Periodontal Disorders
Lead Sponsor:
Midwestern University
Conditions:
Periodontal Disease, Staging, Salivary Markers, Diagnosis
Eligibility:
All Genders
30-99 years
Brief Summary
The swelling of the gum, or periodontitis, is the leading cause for tooth loss, and currently affects up to 65 million adults only in the United States. One of the reasons for the widespread of period...
Detailed Description
There is an urgent need for an efficient system to diagnose periodontal disease in its early stages. A recent investigation on the prevalence of periodontitis in adults living in the USA revealed that...
Eligibility Criteria
Inclusion
- (1) 40 years of age or older with a healthy medical history and not meeting any of the exclusion criteria;
- (2) requiring definitive periodontal treatment/routine care; and
- (3) retaining a minimum of 20 teeth and without active carious lesions
Exclusion
- 1\) with systemic illness affecting their immune system (i.e. diabetes, rheumatoid arthritis, etc);
- (2) currently on chronic anti-inflammatory medications (i.e. steroids, TNFα-inhibitors, etc); and
- (3) previously underwent active periodontal therapy within the past 2 years;
- (4) who cannot read or speak English.
Key Trial Info
Start Date :
November 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 10 2024
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT06576856
Start Date
November 6 2021
End Date
October 10 2024
Last Update
October 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Midwestern Univerity
Downers Grove, Illinois, United States, 60515